All Photos(1)
Key Documents
Safety Information
SHPH15
MISSION® LentiPlex® Human Pooled shRNA Library TRC1.5
For Rapid, Convenient Genome-wide shRNA Screens
Sign Into View Organizational & Contract Pricing
Select a Size
10 G
CN¥626.68
25 G
CN¥634.47
100 G
CN¥3,511.98
All Photos(1)
Select a Size
Change View
10 G
CN¥626.68
25 G
CN¥634.47
100 G
CN¥3,511.98
About This Item
UNSPSC Code:
41105904
NACRES:
NA.51
Recommended Products
Quality Level
product line
MISSION®
concentration
≥5x108 VP/ml (via p24 assay)
technique(s)
capture ELISA: 5 x 108 TU/mL using p24
shipped in
dry ice
storage temp.
−70°C
Related Categories
1 of 4
This Item | N4876 | NX0403 | 106762 |
|---|---|---|---|
| Quality Level 200 | Quality Level 200 | Quality Level 100 | Quality Level 100 |
| solubility H2O: passes test | solubility ethanol: 100 mg/mL, H2O: 50 mg/mL (with sonication) | solubility - | solubility - |
| form solid | form powder | form - | form solid |
| mp 250 °C (dec.) (lit.) | mp 250 °C (dec.) (lit.) | mp - | mp 250-258 °C (decomposition) |
| grade ACS reagent | grade - | grade - | grade ACS reagent |
| description identification and melting point passes test | description - | description - | description - |
General description
MISSION LentiPlex Pooled Libraries bring the power of the MISSION TRC shRNA collection together with Sigma′s lentiviral manufacturing expertise to enable genome-wide RNAi screens at your bench-top. The LentiPlex pooled system provides enhanced delivery and long-term gene silencing in non-dividing and primary cell lines allowing unlimited discovery potential. The convenient format now makes rapid whole-genome RNAi screens accessible to any researcher with minimal reagent, time or capital equipment investment.
The MISSION LentiPlex Human shRNA Pooled Library 1.5 includes additional gene and clone coverage from the previously offered LentiPlex 1.0 Pooled Library . With the addition of 1.5, which consists of 4,000+ human genes and 10,000+ total clone coverage divided into 3 subpools, the complete whole-genome human library complete whole-genome human librarynow consists of over 110,000 shRNA constructs from the TRC collection targeting 21,000+ human genes. Each library is tested for shRNA representation before product release to ensure robust library coverage. The complete library is provided in ready-to-use lentiviral format at titers of at least 5 x 108 TU/ml via p24 assay and is pre-divided into sixteen subpools of approximately 6,000-8,000 shRNA constructs each. Amplification and sequencing primers are also provided for downstream target identification.
For more information including sample data and uses, please visit our LentiPlex Technical Detail Page.
The MISSION LentiPlex Human shRNA Pooled Library 1.5 includes additional gene and clone coverage from the previously offered LentiPlex 1.0 Pooled Library . With the addition of 1.5, which consists of 4,000+ human genes and 10,000+ total clone coverage divided into 3 subpools, the complete whole-genome human library complete whole-genome human librarynow consists of over 110,000 shRNA constructs from the TRC collection targeting 21,000+ human genes. Each library is tested for shRNA representation before product release to ensure robust library coverage. The complete library is provided in ready-to-use lentiviral format at titers of at least 5 x 108 TU/ml via p24 assay and is pre-divided into sixteen subpools of approximately 6,000-8,000 shRNA constructs each. Amplification and sequencing primers are also provided for downstream target identification.
For more information including sample data and uses, please visit our LentiPlex Technical Detail Page.
Other Notes
The MISSION LentiPlex Human Pooled shRNA Libraries consist of Catalog Numbers SHPH01, SHPH15, SHPH2, and SHPHLIBR. Please refer to Table 1 for approximate number of shRNA clone coverage, targeted genes, and subpools for each library.
Amplification and sequencing primers are also provided for downstream hit identification.
Deconvolution of shRNA Pools
Sigma′s deconvolution service lets you easily identify the genes that impact your pooled shRNA screen.
Contact your local Sigma sales representative for more information or submit an inquiry to MISSION RNAi
Amplification and sequencing primers are also provided for downstream hit identification.
Deconvolution of shRNA Pools
Sigma′s deconvolution service lets you easily identify the genes that impact your pooled shRNA screen.
- Next-generation sequencing of clonesgives a precise number of individual clone occurrence within a pooled shRNA sample
- Comprehensive, reproducible results from pooled shRNA screens
- Statistically robust and information-rich data
Contact your local Sigma sales representative for more information or submit an inquiry to MISSION RNAi
Recommended products
Browse additional MISSION shRNA Gene Family Sets in our MISSION shRNA portal.
Legal Information
LentiPlex is a registered trademark of Merck KGaA, Darmstadt, Germany
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
高风险级别生物产品--病毒，疫苗等
含少量动物源组分生物产品
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Christine Karlsson et al.
Methods in molecular biology (Clifton, N.J.), 650, 29-43 (2010-08-06)
Identifying the genes and pathways that regulate self-renewal and differentiation in somatic stem cells is a central goal in stem cell and cancer biology. Here, we describe a method for RNAi-based screens in primary human hematopoietic stem and progenitor cells.
Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK.
Lin, Yu-yi, et al.
Nature (2012)
Richard Possemato et al.
Nature, 476(7360), 346-350 (2011-07-16)
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology
Articles
RNAi Consortium (TRC): Collaborative effort among academic labs and biotech/pharma institutes advancing RNA interference research.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
